Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rhizome AI
AddedJun 25, 2026
UpdatedJul 2, 2026
Rhizome AI

Rhizome AI

Seed

Agent Platform for Life Sciences.

HQ
New York City, NY, US
Accelerator
Y Combinator logoY CombinatorW26
Overview
Compare
Fundraising
Employees

It takes 500,000 days of office work to bring a drug to market. To get there, we need agents doing most of the work. Today, our research agent is the best way to know what the FDA thinks.

Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss.

Rhizome AI - Similar Companies

Convexia logo

Convexia

convexia.bio

Ritivel logo

Ritivel

ritivel.com

CellType logo

CellType

celltype.com

Enjamb Labs logo

Enjamb Labs

enjamb.ai

Delineate logo

Delineate

delineate.pro

The Synthesis Company logo

The Synthesis Company

Cohesion logo

Cohesion

Soria logo

Soria

soriaanalytics.com

Alpha Research logo

Alpha Research

alpharesearch.nyc

Panacea logo

Panacea

withpanacea.com

Maven Bio logo

Maven Bio

mavenbio.com

Airweave logo

Airweave

airweave.ai

Undermind logo

Undermind

undermind.ai

Fed10 logo

Fed10

fed10.ai

Baseline AI logo

Baseline AI

baselinetrials.com

Rhizome AI - Quick Facts

Who are Rhizome AI's competitors?

Companies similar to Rhizome AI include Convexia, Ritivel, CellType and Enjamb Labs.

Where is Rhizome AI's headquarters located?

Rhizome AI's headquarters is located in New York City, NY, US.

When was Rhizome AI's last funding round?

Rhizome AI's most recent funding round was for $500k (USD) in January 2026.

How much has Rhizome AI raised to-date?

As of Jan 1, 2026, Rhizome AI has raised a total of $500k (USD).